Healthcare / Diagnostics & Research

Waters Corporation (WAT)

$371.93
-1.65%
$37.7B
Market Cap
48.8
P/E Ratio
1.14
Beta
Dividend Yield
Piotroski 4/9Altman Z 11.7 SafeBeneish M -2.38 CleanROIC−WACC +5.0%

Quantitative Summary

Deterministic

WAT trades at 48.8x earnings, roughly in line with its sector average of 65.2x. Financial health is average: Piotroski 4/9, Altman Z 11.7. DCF fair value of $49 implies 85% downside based on model assumptions.

Generated deterministically from quant metrics and financial statements. Not a recommendation.

Algorithmic Teardown

AI-Generated

The fundamental economics of Waters Corporation reflect a high-quality earnings engine driven primarily by superior profitability rather than operational leverage or balance sheet expansion. The company generates an ROIC-WACC spread of 5.0%, indicating value creation that outpaces the cost of capital, while DuPont analysis reveals this return stems from robust net margins at 20.3% and moderate asset turnover of 0.62x supported by a leverage multiplier near 2.0x. Qualitative risk metrics present a mixed picture; although the Altman Z-Score of 11.1 and negative Beneish M-Score of -2.38 suggest low distress probability and minimal earnings manipulation, the Piotroski F-Score of 4/9 signals moderate financial stability relative to peers. Despite these structural strengths, recent performance has underperformed broad factor models, evidenced by an annualized Fama-French Alpha of -37.37% and a neutral stance on value factors (HML), even as the Profitability Factor remains robust at 0.221.

Valuation metrics indicate significant divergence between current market pricing and intrinsic model estimates. Trading at a forward P/E of 28.2x, the stock is notably undervalued relative to its sector average of 36.8x, yet this discount aligns with a DCF-derived fair value that implies an -83.7% downside from current levels based on projected free cash flow growth assumptions. This steep valuation gap suggests the market may be pricing in aggressive long-term headwinds despite management's implied ability to sustain high FCF expansion rates over ten years at 32.6%. The disconnect between strong historical profitability and a deeply discounted multiple highlights potential concerns regarding future visibility or execution risk that are not captured by static margin analysis alone.

Recent insider activity provides a counter-narrative to the bearish valuation thesis, with $451,070 in net buying over the last 90 days suggesting management confidence despite the wide DCF gap. However, investors must weigh this internal support against the persistent underperformance relative to factor-based benchmarks and the substantial implied discount required by the DCF model. The synthesis of strong fundamental generation metrics with a deeply depressed valuation creates an asymmetric setup where realized returns depend heavily on whether future growth assumptions converge closer to current market expectations or if the stock re-rates based on improved operational momentum.

Generated by LLM from quantitative data inputs. May contain inaccuracies. Not investment advice.

DCF Sandbox

Interactive
Market Price
$371.93
Fair Value
$48
Implied Upside
-87.1%
$48IMPLIED FAIR VALUEOVERVALUEDOVERUNDER
Growth Rate (Y1–5)-1%
-10%20%50%
Discount Rate (WACC)12.0%
5%12.5%20%

5-year two-stage DCF. Terminal growth 3%. Default sliders match the pre-computed base case. Drag to explore scenarios. Not investment advice.

Reverse DCFMarket-Implied
33.9%annual FCF growth priced in at $371.93

The growth rate the market implicitly expects over the next 10 years to justify today's price. Compare with historical growth of 7% YoY revenue.

Sensitivity Matrix

TG ↓ / WACC →10%12%14%
2%$57$45$37
3%$64$49$39
4%$73$53$42

Center = base case. Green = >10% upside, Red = >10% downside vs $371.93.

Pre-computed DCF: WACC=12.0%, terminal growth 3%. Fair value $49 (-85.0%). Not investment advice.

Valuation Context

48.8x
WAT P/E
65.2x
Sector Avg
83.9x
5Y Avg P/E
-25%
vs Sector

Currently trading 65% below its 5-year average P/E of 83.9x.

Price Chart with Moving Averages

Loading chart...
SMA 50 SMA 200

Technical Setup

AI Generated

Waterstone Medical Retail Group Inc. (WAT) is trading below both its 50-day and 200-day simple moving averages, suggesting it may be in a short-term downtrend relative to recent price action. The Relative Strength Index (RSI) reading of 28.1 indicates that the stock is currently in oversold territory, which could signal potential near-term buying pressure or stabilization based on historical patterns.

RSI (14)
SMA 50
SMA 200

Quant Health Deep Dive

4/9
Piotroski F-Score
Average — mixed operational signals
11.7
Altman Z-Score
Safe Zone — above 3.0 threshold per academic model. Thresholds: >3 safe, 1.8–3 grey, <1.8 distress.
-2.38
Beneish M-Score
Below threshold — no statistical earnings quality concern per Beneish model. Threshold: <-2.22 = below threshold.

Profitability & Value Creation

59.3%
Gross Margin
20.3%
Net Margin
17.0%
ROIC
12.0%
WACC
ROIC − WACC Spread: +5.0%— Positive spread.
+7.0%
Revenue Growth (YoY)
+0.8%
Earnings Growth (YoY)
539.8M
Free Cash Flow

DuPont Analysis — ROE Decomposition

Breaking down Return on Equity to see how the company generates its ROE — efficiency, margins, or leverage.

20.3%
Net Profit Margin
NI ÷ Revenue
×
0.62x
Asset Turnover
Revenue ÷ Assets
×
1.98x
Equity Multiplier
Assets ÷ Equity
=
25.1%
Return on Equity
✅ ROE driven primarily by strong profit margins — a sign of pricing power.

Balance Sheet Health

0.98x
Debt / Equity
1.73x
Current Ratio
11.9x
Interest Coverage
0.3x
Net Debt / EBITDA
1.70%
FCF Yield
1.0B
EBITDA

Insider Activity (Last 90 Days)

Net Insider Flow
+$451,070
Net Buying
2
Buy Transactions
0
Sale Transactions
2026-03-16JIANG WEIBuy$144,730
2026-03-06FEARON RICHARD HBuy$306,340
2026-02-25CHAUBAL AMOLGrant1,455 shares
2026-02-25BATRA UDITGrant5,165 shares
2026-02-25HUANG PEARL S.Grant23 shares

Open-market buys vs sells by company insiders. Source: yfinance.

Earnings Surprise History

Q4
✓ Beat
Est: $2.22
Act: $2.25
+1.2%
Q3
✓ Beat
Est: $2.94
Act: $2.95
+0.3%
Q2
✓ Beat
Est: $3.22
Act: $3.40
+5.5%
Q1
✓ Beat
Est: $4.51
Act: $4.53
+0.5%

EPS estimates vs actuals for the most recent reported quarters. Source: yfinance.

Risk Profile

37.5%
Annual Volatility
-0.05
Sharpe (1Y)
-30.5%
Max Drawdown (5Y)

Sharpe = risk-adjusted return (higher is better). Max drawdown = largest peak-to-trough decline. 1,200+ trading days.

Underwater (Drawdown from Peak)

How far below the all-time high the price has been over time. Deeper = more pain for holders.

Loading drawdown chart...

Rolling 60-Day Beta vs S&P 500 (VOO)

How the stock's sensitivity to market moves changes over time. β > 1 = more volatile than the market.

Loading beta chart...
Rolling Beta Market (β = 1.0)

Fama-French 5-Factor Exposure

Academic factor model decomposition — what's really driving this stock's returns.

1.02
Market β
Mkt-RF
+0.633
Size (SMB)
Small-cap tilt
-0.070
Value (HML)
Neutral
+0.221
Profit (RMW)
Robust
+1.304
Invest (CMA)
Conservative
Alpha (annual): -37.37%
R²: 37.7%of variance explained by 5 factors

Fama-French 5-Factor Model. Data: Kenneth French Data Library. Regression over 3 years of daily returns.

Fundamentals

23.4
Forward P/E
1.63
PEG Ratio
8.92
Price/Book
1M
Avg Volume
$414.15
52W High
$275.05
52W Low
70%
52W Range Position

Passive Flow Attribution

ETF Draft Effect
$4.2B
Tracked Passive Exposure
8
ETFs Holding WAT
0.06%
Avg Weight in ETFs
$6.6T
Total ETF AUM

When investors buy or sell ETFs like VOT or XLV, the fund manager is mechanically forced to buy or sell WAT shares regardless of Waters Corporation's individual fundamentals. We estimate $4.2B of passive capital is structurally linked to WAT through 8 tracked ETFs. Index rebalances and ETF creation/redemption cycles can create noticeable volume spikes unrelated to company news.

Passive exposure = Σ (ETF AUM × stock weight in ETF) across 8 tracked ETFs. Actual passive ownership is larger (includes mutual funds). Not investment advice.

ETF Contagion Visualizer

Simulate a price drop in Waters Corporation to visualize passive redemption contagion across ETFs and collateral stocks.

WAT Shock
-0%
Est. Passive Redemption
$0
Systemic Risk
STABLE
WATEpicenterVTIETFVOOETFIVVETFLLYLow RiskLLYLow RiskJNJLow RiskJNJLow RiskABBVMed Risk
WAT Price Drop (%)0

If Waters Corporation (WAT) experiences a significant drawdown, ETF redemptions can create collateral selling pressure on co-held stocks. Our model identifies ELI LILLY + CO (LLY) as the most exposed collateral stock, sharing 1 ETFs with WAT. This is the "Passive Contagion" effect described in the Inelastic Market Hypothesis.

Contagion model based on shared ETF exposure and constituent weights across 30 tracked ETFs. Estimated selling pressure is a simplified model — actual impact depends on market liquidity, ETF redemption mechanics, and market-maker activity.

WAT Ownership Dynamics

Passive funds hold 1 in every 7 WAT shares, reducing daily market volatility.

Ticker
WAT
Total Shares
98M
ETF Lock-Up
14.4%
Display Mode
Total Float Impact
14.4%Locked Float

Waters Corporation (WAT) exerts measurable gravity on the passive index market, currently representing 0.7% of the VOT (VOT) and 0.6% of the State Street Health Care Select Sector SPDR ETF (XLV). Across 30 tracked ETFs, approximately 14M shares (14.4% of float) are held by passive funds and rarely trade on the open market. This level of passive ownership means index rebalances can create outsized volume events.

Float lock-up computed from 30 ETFs tracked by SecuritiesDB. Actual passive ownership is higher (includes mutual funds, pension funds, etc.).

WAT Institutional Volume Profile

252-day volume distribution by price level. The Point of Control (POC) marks the price where the most institutional volume transacted — an implicit support/resistance floor.

TICKER
WAT
PRICE
$371.93
FLOOR (POC)
$299.39
STRENGTH
High
$279$285$2928%$299POC 13%$3069%$313$3208%$3278%$3347%$341$3486%$355$362$369$371.93$376$383$390$397$404$411
Focus Zone
Point of Control (POC) Support (below price) Resistance (above price) Current Price

The highest-volume price zone for Waters Corporation over the past year sits near $299.39 (13% of 252-day volume). The current price of $371.93 trades 24.2% above this institutional floor — a sign of upside momentum, though a pullback to the POC zone is a common reversion target. The highly concentrated volume profile (13% at POC) indicates strong consensus on fair value — institutional participants have repeatedly transacted near this price.

Volume Profile computed from 252 trading days of OHLCV data. Volume allocated to price bins proportionally based on daily high-low range. Not investment advice.

WAT Capital Efficiency

How efficiently does Waters Corporation convert operating profits into free cash? The FCF Conversion ratio measures the gap between accounting earnings and real cash generation.

Free Cash Flow
$540M
EBITDA
$1.0B
FCF Conversion
52%
Reinvestment Rate
48%
52% of EBITDA → Free Cash
0% (cash burn)25% (low)50% (efficient)100% (pure cash)
ROIC
17.0%
ROIC − WACC Spread
5.0%

Waters Corporation converts 52% of its EBITDA into free cash flow, a healthy conversion rate indicating efficient capital management — the business generates substantial cash after reinvestment. The positive ROIC-WACC spread of 5.0% confirms that reinvested capital creates shareholder value.

Capital efficiency = Free Cash Flow ÷ EBITDA. Reinvestment = (EBITDA − FCF) ÷ EBITDA. Metrics from latest annual filings. Not investment advice.

Fails-to-Deliver (FTD) History

SEC-reported settlement failures. Elevated FTDs can indicate high short-selling pressure, operational settlement issues, or naked shorting activity.

DateFailed SharesClose PriceNotional Value
2026-05-14488$334.93$163,445.84
2026-05-1324,817$352.21$8.7M
2026-05-12253$348.07$88,061.71
2026-05-064,879$342.75$1.7M
2026-05-052,241$301.88$676,513.08
2026-05-04474$307.12$145,574.88
2026-04-29478$300.73$143,748.94
2026-04-2756$309.87$17,352.72
2026-04-24462$311.20$143,774.4
2026-04-232,397$334.38$801,508.86
2026-04-22658$335.23$220,581.34
2026-04-211,000$335.61$335,610
2026-04-20881$327.77$288,765.37
2026-04-179,933$319.04$3.2M
2026-04-16962$326.20$313,804.4
2026-04-13743$320.00$237,760
2026-04-10380$317.65$120,707
2026-04-081,802$307.38$553,898.76
2026-04-0238$299.89$11,395.82
2026-03-274,648$300.56$1.4M
2026-03-2511$301.92$3,321.12
2026-03-23564$298.99$168,630.36
2026-03-20141$299.57$42,239.37
2026-03-19374$295.05$110,348.7
2026-03-18123$296.99$36,529.77
2026-03-17271$290.02$78,595.42
2026-03-1342,770$283.32$12.1M
2026-03-0914,857$302.54$4.5M
2026-03-067,075$315.59$2.2M
2026-03-05252$319.04$80,398.08

Source: SEC Regulation SHO FTD data. Data is reported with a ~30 day delay. High FTD quantities relative to average daily volume may indicate settlement stress.

Price Correlations

Statistical correlation of daily returns with other stocks. High correlations indicate stocks that move together; negative correlations can offer diversification.

Peer252-Day (1Y)126-Day (6M)Direction
WTGXXNaNNaN
A0.7310.599High co-movement
MTD0.6780.516Moderate
DHR0.6690.489Moderate
TMO0.6410.507Moderate
GEHC0.5160.458Moderate
MRK0.5010.425Moderate
NDSN0.4950.393Moderate
IQV0.4940.312Moderate
SWK0.4840.350Moderate

Pearson correlation of daily log returns. 252d ≈ 1 trading year. Computed from price history. Not investment advice.

Compare WAT to Peers

Quant metrics computed deterministically from financial statements and price data. Updated: 2026-06-02.

SecuritiesDB provides programmatic data aggregation for informational purposes only. None of the metrics, summaries, or algorithmic flags constitute a recommendation to buy or sell any security.